Medical Devices: Page 80
-
Deep Dive
Apple locked in court battles with small medtech firms over allegations of stolen technology
AliveCor and Masimo are looking to bar Apple from selling watches that use technology the firms claim they invented.
By Elise Reuter , Nick Paul Taylor • Updated Dec. 13, 2022 -
Boston Scientific pays $523M for control of Chinese device maker Acotec
The acquisition will give Boston greater access to the Chinese market, which the U.S. firm expects will account for 25% of the global medtech demand by 2030.
By Peter Green • Dec. 12, 2022 -
Explore the Trendlineâž”
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal
The companies planned to launch a customized version of the YpsoPump that used pre-filled insulin cartridges for Lilly’s rapid-acting insulins.
By Nick Paul Taylor • Dec. 12, 2022 -
EU Health Commissioner proposes MDR delay to prevent medical device shortages
Plans to delay MDR certification to 2027 for high-risk devices and 2028 for others may still not be enough to stave off shortages.
By Nick Paul Taylor • Updated Dec. 23, 2022 -
Investors hand Vaxxas $23M to support trial of needle-free COVID-19 vaccine
With support from the Gates Foundation, the needle-free technology could get more people vaccinated and avoid cold-chain issues.
By Nick Paul Taylor • Dec. 12, 2022 -
Q&A
Friday Q&A: GE Healthcare’s Arduini, Zodl talk about spinoff, M&A, margins, Jack Welch
The CEO and CFO of the company spoke with MedTech Dive just weeks before the healthcare business formally separates from General Electric.
By Peter Green • Dec. 9, 2022 -
Chinese market recovery could spur international medtech growth in 2023: Goldman
A gradual return to normal and a new government quota could ramp up medical device sales in China later in 2023, the analysts wrote.
By Nick Paul Taylor • Dec. 9, 2022 -
Cochlear’s $120M purchase of hearing-implant maker stirs European scrutiny
The European Commission said the merger “threatens to significantly affect competition in the market for cochlear implants and bone conduction solutions.”
By Nick Paul Taylor • Dec. 9, 2022 -
Dexcom’s G7 glucose monitor wins awaited FDA clearance
The new Dexcom monitor is expected to generate significant patient demand, as it has been cleared by the FDA for patients with Type 1 and Type 2 diabetes, as well as gestational diabetes.
By Elise Reuter • Dec. 8, 2022 -
Edwards CEO Mussallem to retire, Bernard Zovighian named successor
Michael Mussallem will step down in May after leading the company for more than 20 years.
By Elise Reuter • Dec. 8, 2022 -
AdvaMed asks FDA to withdraw divisive draft guidance on LASIK surgery
Some comments were more supportive, with the American Optometric Association calling the agency’s proposal “timely and beneficial.”
By Nick Paul Taylor • Dec. 8, 2022 -
FDA outlines benefits and risks of emerging augmented and virtual reality medical devices
AR/VR may increase access to healthcare and make procedures less invasive, but could potentially cause cybersickness and head and neck strain.
By Nick Paul Taylor • Dec. 8, 2022 -
Apple prevails in AliveCor patent dispute ahead of potential Watch import ban
Patent board ruled that all 30 claims are unpatentable because they are obvious in view of other patents.
By Nick Paul Taylor • Dec. 8, 2022 -
Stanford’s smart bandages accelerate wound healing in preclinical tests
The bandages deliver electrical stimulation to accelerate wound healing in mice by 25% compared to standard sterile dressings.
By Nick Paul Taylor • Dec. 7, 2022 -
Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M
Indego and planned robotic assisted orthotic and prosthetic devices will slot into a portfolio of wearable robotics designed to tackle mobility loss.
By Nick Paul Taylor • Dec. 7, 2022 -
Retrieved from Medtronic on September 19, 2022
Excess deaths to continue constraining recovery of TAVR market in 2023: Goldman
Hospital staffing shortages and excess deaths among seniors are expected to slow the recovery of structural heart procedures, Goldman Sachs analysts said.
By Nick Paul Taylor • Dec. 7, 2022 -
Abiomed’s Impella RP heart pump finds use limited after FDA review of critically ill patients
It's a setback for the company, which hoped the right ventricle pump would have a wider use. A post-approval study showed a low survival rate for the sickest patients.
By Elise Reuter • Updated Dec. 6, 2022 -
Zimmer, Boston Scientific set to lead positive medical device pricing trend in 2023: analysts
As inflation rose, medical device companies were able to secure higher prices in large contracts, which Goldman Sachs analysts wrote “should only be the beginning.”
By Nick Paul Taylor • Dec. 6, 2022 -
AI detects prediabetes in CGM data, opening up new use for device: study
By correctly identifying many patients with prediabetes or Type 2 diabetes, researchers say CGMs can be used to prevent the disease.
By Nick Paul Taylor • Dec. 6, 2022 -
Reducing medtech waste: new PVC recycling process unlocks opportunity
Researchers have identified a way to recycle the PVC that is widely used in medical technologies such as tubing and blood bags.
By Nick Paul Taylor • Dec. 6, 2022 -
Getinge heart support devices join FDA shortage list as raw-materials supply slows production
Maintenance cycles for pumps and batteries have been extended and Getinge asked hospitals to share underutilized devices.
By Nick Paul Taylor • Dec. 5, 2022 -
Vulnerability in BD’s infusion pump flagged to US cybersecurity agency
An attacker with physical access to the device could exploit the vulnerability to change the configuration settings or disable the pump.
By Nick Paul Taylor • Updated Dec. 6, 2022 -
Medtech procedure volume pressures ease on healthcare hiring: Goldman
The evidence offers support for the analysts’ expectation that U.S. procedures will “modestly” improve next year in both inpatient and outpatient settings.
By Nick Paul Taylor • Dec. 5, 2022 -
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Integra to buy Surgical Innovation Associates for $50M in bid to lead growing breast reconstruction niche
Human-derived surgical matrices dominate the market but Interga thinks synthetic and xenograft devices will gain ground.
By Nick Paul Taylor • Dec. 2, 2022